<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="https://bio.scai.fraunhofer.de/ontology/CTO"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     ontologyIRI="https://bio.scai.fraunhofer.de/ontology/CTO">
    <Prefix name="" IRI="https://bio.scai.fraunhofer.de/ontology/CTO"/>
    <Prefix name="dc" IRI="http://purl.org/dc/elements/1.1/"/>
    <Prefix name="obo" IRI="http://purl.obolibrary.org/obo/"/>
    <Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/>
    <Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/>
    <Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/>
    <Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/>
    <Prefix name="foaf" IRI="http://xmlns.com/foaf/0.1/"/>
    <Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/>
    <Prefix name="terms" IRI="http://purl.org/dc/terms/"/>
    <Prefix name="protege" IRI="http://protege.stanford.edu/plugins/owl/protege#"/>
    <Prefix name="oboInOwl" IRI="http://www.geneontology.org/formats/oboInOwl#"/>
    <Prefix name="statistics" IRI="http://purl.org/net/OCRe/statistics.owl#"/>
    <Prefix name="study_protocol" IRI="http://purl.org/net/OCRe/study_protocol.owl#"/>
    <Import>http://ontofox.hegroup.org/DRON_import.owl</Import>
    <Import>http://ontofox.hegroup.org/ERO_import.owl</Import>
    <Import>http://ontofox.hegroup.org/IAO4_imports.owl</Import>
    <Import>http://ontofox.hegroup.org/OBI_import11.owl</Import>
    <Import>http://ontofox.hegroup.org/OBI_import12.owl</Import>
    <Import>http://ontofox.hegroup.org/OBI_import13.owl</Import>
    <Import>http://ontofox.hegroup.org/OGMS_import2.owl</Import>
    <Import>http://ontofox.hegroup.org/OPMI12_import.owl</Import>
    <Import>http://ontofox.hegroup.org/OPMI13_imports.owl</Import>
    <Import>http://ontofox.hegroup.org/OPMI14_imports.owl</Import>
    <Import>http://ontofox.hegroup.org/OPMI15_imports.owl</Import>
    <Import>http://ontofox.hegroup.org/OPMI16_imports.owl</Import>
    <Import>http://ontofox.hegroup.org/VO_import1.owl</Import>
    <Import>http://purl.obolibrary.org/obo/IAO_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/IAO_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/IAO_import3.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCBITaxon_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCBITaxon_import6.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import10.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import11.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import12.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import15.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import16.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import17.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import18.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import19.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import20.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import21.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import22.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import23.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import24.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import25.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import3.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import4.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import5.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import7.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import8.owl</Import>
    <Import>http://purl.obolibrary.org/obo/NCIT_import9.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OAE_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OAE_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import10.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import3.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import4.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import5.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import6.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import7.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import8.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OBI_import9.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OGMS_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OMPI2_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OMRSE_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import10.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import11.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import2.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import3.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import4.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import5.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import6.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import7.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import8.owl</Import>
    <Import>http://purl.obolibrary.org/obo/OPMI_import9.owl</Import>
    <Import>http://purl.obolibrary.org/obo/PATO_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/PDRO_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/human_study_import.owl</Import>
    <Import>http://purl.obolibrary.org/obo/bfo/2019-08-26/bfo.owl</Import>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Asiyah Yu Lin (CDRH, Food and Drug Administration)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Astghik Sargsyan (Fraunhofer SCAI)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Geena Mariya Jose (Causality Biomodels)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Leon Li (NIH)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Oliver He (University of Michigan)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
        <Literal>Shounak Baksi (Causality Biomodels)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <Literal xml:lang="en">The core Ontology of Clinical Trials (CTO) will serve as a structured resource integrating basic terms and concepts in the context of clinical trials. Thereby covering clinicaltrails.gov. CoreCTO will serve as a basic ontology to generate extended versions for specific applications such as annotation of variables in study documents from clinical trials.</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <Literal>Alpha Tom Kodamullil (Fraunhofer SCAI)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <Literal>Johannes Darms (Fraunhofer SCAI)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <Literal>Stephan Gebel (Fraunhofer SCAI)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <Literal>Sumit Madan (Fraunhofer SCAI)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:license"/>
        <Literal>http://creativecommons.org/licenses/by/4.0</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <Literal>CTO: Core Ontology of Clinical Trials</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="owl:versionInfo"/>
        <Literal>Version Release: 1.0.0</Literal>
    </Annotation>
    <Declaration>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:IAO_0000030"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:IAO_0000300"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCBITaxon_1"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCBITaxon_7742"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCBITaxon_9606"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C129000"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C15238"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C15600"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C15601"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C15602"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C15603"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C25150"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C25320"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C48355"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C52580"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C70793"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C70817"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C70840"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C82638"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C84336"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C90467"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C90468"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C90469"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C93360"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C98722"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C98747"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C98772"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:NCIT_C98781"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OAE_0000002"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OBI_0000011"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OBI_0000115"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OBI_0000272"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OBI_0500027"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:OPMI_0000223"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:PATO_0001241"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="obo:PDRO_0000129"/>
    </Declaration>
    <Declaration>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Interventional_study"/>
    </Declaration>
    <Declaration>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Observational_study"/>
    </Declaration>
    <Declaration>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Quantitative_human_study"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Australian_New_Zealand_clinical_trials_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Brazilian_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chinese_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cuban_public_registry_of_clinical_trials_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#EU_clinical_trials_register"/>
    </Declaration>
    <Declaration>
        <Class IRI="#German_clinical_trials_register"/>
    </Declaration>
    <Declaration>
        <Class IRI="#German_clinical_trials_register_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Indian_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#International_standard_randomised_controlled_trial_register_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Iranian_registry_of_clinical_trials_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Korean_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lebanese_clinical_trials_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pan_African_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Peruvian_clinical_trial_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sri_Lanka_clinical_trials_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thai_clinical_trials_registry_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#The_Netherlands_national_trial_register_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#age_between_18_and_64"/>
    </Declaration>
    <Declaration>
        <Class IRI="#age_between_birth_and_17_years"/>
    </Declaration>
    <Declaration>
        <Class IRI="#age_older_than_64"/>
    </Declaration>
    <Declaration>
        <Class IRI="#healthy_volunteer_criterion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#human_subjects_protection_review_board_status"/>
    </Declaration>
    <Declaration>
        <Class IRI="#masking_design"/>
    </Declaration>
    <Declaration>
        <Class IRI="#number_of_participants"/>
    </Declaration>
    <Declaration>
        <Class IRI="#other_outcome_measure_information"/>
    </Declaration>
    <Declaration>
        <Class IRI="#outcome_measure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#outcome_measure_result"/>
    </Declaration>
    <Declaration>
        <Class IRI="#outcome_specification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#phase_not_applicable"/>
    </Declaration>
    <Declaration>
        <Class IRI="#primary_outcome_measure_information"/>
    </Declaration>
    <Declaration>
        <Class IRI="#prospective_study_design"/>
    </Declaration>
    <Declaration>
        <Class IRI="#retrospective_study_design"/>
    </Declaration>
    <Declaration>
        <Class IRI="#secondary_identifier"/>
    </Declaration>
    <Declaration>
        <Class IRI="#secondary_outcome_measure_information"/>
    </Declaration>
    <Declaration>
        <Class IRI="#study_result"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
    </Declaration>
    <SubClassOf>
        <Class abbreviatedIRI="obo:IAO_0000300"/>
        <Class abbreviatedIRI="obo:IAO_0000030"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCBITaxon_1"/>
        <Class abbreviatedIRI="obo:BFO_0000040"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCBITaxon_40674"/>
        <Class abbreviatedIRI="obo:NCBITaxon_7742"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCBITaxon_7742"/>
        <Class abbreviatedIRI="obo:NCBITaxon_2759"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCBITaxon_9606"/>
        <Class abbreviatedIRI="obo:NCBITaxon_40674"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C129000"/>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Observational_study"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
        <Class abbreviatedIRI="obo:OBI_0000115"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15238"/>
        <Class abbreviatedIRI="obo:OAE_0000002"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15245"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15329"/>
        <Class abbreviatedIRI="obo:OAE_0002807"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15600"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15601"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15602"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15603"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15693"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15694"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C15714"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C25320"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty abbreviatedIRI="obo:BFO_0000051"/>
            <Class IRI="#primary_outcome_measure_information"/>
        </ObjectSomeValuesFrom>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C25320"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty abbreviatedIRI="obo:BFO_0000051"/>
            <Class IRI="#secondary_outcome_measure_information"/>
        </ObjectSomeValuesFrom>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C48355"/>
        <Class abbreviatedIRI="obo:NCBITaxon_9606"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C49653"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C49656"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C49657"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C52580"/>
        <Class abbreviatedIRI="obo:OBI_0000115"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
        <Class abbreviatedIRI="obo:IAO_0000300"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C70793"/>
        <Class abbreviatedIRI="obo:NCIT_C48355"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C70817"/>
        <Class abbreviatedIRI="obo:OBI_0000272"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C70840"/>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Interventional_study"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C71485"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C71486"/>
        <Class abbreviatedIRI="obo:NCIT_C147141"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C82638"/>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Interventional_study"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C84336"/>
        <Class abbreviatedIRI="obo:NCBITaxon_9606"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C90467"/>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C90468"/>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C90469"/>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C93360"/>
        <Class abbreviatedIRI="obo:PDRO_0000129"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C98722"/>
        <Class IRI="http://purl.org/net/OCRe/research.owl#Quantitative_human_study"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C98747"/>
        <Class abbreviatedIRI="obo:OBI_0000011"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C98772"/>
        <Class IRI="#study_result"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:NCIT_C98781"/>
        <Class IRI="#study_result"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:OPMI_0000223"/>
        <Class abbreviatedIRI="obo:NCIT_C60776"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:OPMI_0004508"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:PATO_0001241"/>
        <Class abbreviatedIRI="obo:BFO_0000019"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="obo:VO_0000596"/>
        <Class abbreviatedIRI="obo:ERO_0000015"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Australian_New_Zealand_clinical_trials_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Brazilian_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chinese_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cuban_public_registry_of_clinical_trials_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#EU_clinical_trials_register"/>
        <Class abbreviatedIRI="obo:OBI_0000245"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#German_clinical_trials_register"/>
        <Class abbreviatedIRI="obo:OBI_0000245"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#German_clinical_trials_register_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Indian_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#International_standard_randomised_controlled_trial_register_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Iranian_registry_of_clinical_trials_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Korean_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lebanese_clinical_trials_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pan_African_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Peruvian_clinical_trial_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sri_Lanka_clinical_trials_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thai_clinical_trials_registry_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#The_Netherlands_national_trial_register_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000578"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#age_between_18_and_64"/>
        <Class abbreviatedIRI="obo:NCIT_C25150"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#age_between_birth_and_17_years"/>
        <Class abbreviatedIRI="obo:NCIT_C25150"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#age_older_than_64"/>
        <Class abbreviatedIRI="obo:NCIT_C25150"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#healthy_volunteer_criterion"/>
        <Class abbreviatedIRI="obo:OBI_0500027"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#human_subjects_protection_review_board_status"/>
        <Class abbreviatedIRI="obo:OPMI_0000326"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#masking_design"/>
        <Class abbreviatedIRI="obo:OBI_0500000"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#number_of_participants"/>
        <Class abbreviatedIRI="obo:IAO_0000027"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#other_outcome_measure_information"/>
        <Class IRI="#outcome_specification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#outcome_measure"/>
        <Class abbreviatedIRI="obo:BFO_0000015"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#outcome_measure_result"/>
        <Class IRI="#study_result"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#outcome_specification"/>
        <Class abbreviatedIRI="obo:IAO_0000033"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#phase_not_applicable"/>
        <Class abbreviatedIRI="obo:ERO_0000016"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#primary_outcome_measure_information"/>
        <Class IRI="#outcome_specification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#prospective_study_design"/>
        <Class abbreviatedIRI="obo:OBI_0500000"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#retrospective_study_design"/>
        <Class abbreviatedIRI="obo:OBI_0500000"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#secondary_identifier"/>
        <Class abbreviatedIRI="obo:IAO_0000030"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#secondary_outcome_measure_information"/>
        <Class IRI="#outcome_specification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#study_result"/>
        <Class abbreviatedIRI="obo:IAO_0000027"/>
    </SubClassOf>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:ERO_0000348</AbbreviatedIRI>
        <Literal>single group of individuals with specific characteristics.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasNarrowSynonym"/>
        <AbbreviatedIRI>obo:IAO_0000578</AbbreviatedIRI>
        <Literal>Primary Registry and Trial Identifying Number</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C129000</AbbreviatedIRI>
        <Literal>An observational study that is also considered to be a Patient Registry. This type of study should only be registered once in the Protocol Registration and Results System (PRS), by the sponsor responsible for the primary data collection and analysis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C142660</AbbreviatedIRI>
        <Literal>Participants are assigned to intervention groups by chance</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C142660</AbbreviatedIRI>
        <Literal>randomized</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C147141</AbbreviatedIRI>
        <Literal>The main objective of the intervention(s) being evaluated by the clinical trial.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:NCIT_C147141</AbbreviatedIRI>
        <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C15238</AbbreviatedIRI>
        <Literal>Genetic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15245</AbbreviatedIRI>
        <Literal>One or more interventions for evaluating the delivery, processes, management, organization, or financing of healthcare.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:NCIT_C15329</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15600</AbbreviatedIRI>
        <Literal>Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15601</AbbreviatedIRI>
        <Literal>Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15602</AbbreviatedIRI>
        <Literal>Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15603</AbbreviatedIRI>
        <Literal>Studies of FDA-approved drugs to delineate additional information including the drug&apos;s risks, benefits, and optimal use.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15693</AbbreviatedIRI>
        <Literal>Trials that are a combination of phases 1 and 2.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15694</AbbreviatedIRI>
        <Literal>Trials that are a combination of phases 2 and 3.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C15714</AbbreviatedIRI>
        <Literal>One or more interventions for examining the basic mechanism of action (for example, physiology or biomechanics of an intervention).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C161319</AbbreviatedIRI>
        <Literal>The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C161319</AbbreviatedIRI>
        <Literal>The name(s) of the disease(s) or condition(s) studied in the clinical study, or the focus of the clinical study. Use, if available, appropriate descriptors from NLM&apos;s Medical Subject Headings (MeSH)-controlled vocabulary thesaurus or terms from another vocabulary, such as the Systematized Nomenclature of Medicine—Clinical Terms (SNOMED CT), that has been mapped to MeSH within the Unified Medical Language System (UMLS) Metathesaurus.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C161319</AbbreviatedIRI>
        <Literal>Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C161319</AbbreviatedIRI>
        <Literal>health condition(s) or problem(s) studied</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C161319</AbbreviatedIRI>
        <Literal>target disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C25150</AbbreviatedIRI>
        <Literal>A type of eligibility criteria that indicates the age a person must be to participate in a clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C49653</AbbreviatedIRI>
        <Literal>One or more interventions are being evaluated for identifying a disease or health condition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C49656</AbbreviatedIRI>
        <Literal>One or more interventions are being evaluated for treating a disease, syndrome, or condition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C49657</AbbreviatedIRI>
        <Literal>One or more interventions are being assessed for preventing the development of a specific disease or health condition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C52580</AbbreviatedIRI>
        <Literal>The method by which participants are assigned to arms in a clinical trial.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:NCIT_C52580</AbbreviatedIRI>
        <Literal>https://www.clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/results_definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C70817</AbbreviatedIRI>
        <Literal>The written description of the clinical study, including objective(s), design, and methods. It may also include relevant scientific background and statistical considerations (if the protocol document includes the statistical analysis plan, use &quot;Study Protocol with SAP and/or ICF&quot; option). Note: All amendments approved by a human subjects protection review board (if applicable), before the time of submission and that apply to all clinical trial Facility Locations must be included.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:NCIT_C70817</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C71485</AbbreviatedIRI>
        <Literal>One or more interventions are assessed or examined for identifying a condition, or risk factors for a condition, in people who are not yet known to have the condition or risk factor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C71486</AbbreviatedIRI>
        <Literal>One or more interventions are evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant&apos;s health or function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C82638</AbbreviatedIRI>
        <Literal>Two or more interventions, each alone and in combination, are evaluated in parallel against a control group</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C98722</AbbreviatedIRI>
        <Literal>An investigational drug product (including biological product) available through expanded access for patients who do not qualify for enrollment in a clinical trial. Expanded Access includes all expanded access types under section 561 of the Federal Food, Drug, and Cosmetic Act: (1) for individual patients, including emergency use; (2) for intermediate-size patient populations; and (3) under a treatment IND or treatment protocol.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:NCIT_C98722</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/expanded_access_definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:NCIT_C98747</AbbreviatedIRI>
        <Literal>For each intervention studied in the clinical study, the general type of intervention.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasNarrowSynonym"/>
        <AbbreviatedIRI>obo:NCIT_C98747</AbbreviatedIRI>
        <Literal>intervention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/results_definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OAE_0000001</AbbreviatedIRI>
        <Literal>Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant’s participation in the research, whether or not considered related to the participant’s participation in the research</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://www.clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OAE_0000002</AbbreviatedIRI>
        <Literal>A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OAE_0000002</AbbreviatedIRI>
        <Literal>Intervention(s)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OAE_0000002</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0000115</AbbreviatedIRI>
        <Literal>A description of the manner in which the clinical trial will be conducted.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0000115</AbbreviatedIRI>
        <Literal>Interventional Study Design</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0002555</AbbreviatedIRI>
        <Literal>A type of eligibility criteria that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups. The age groups are: Child (birth-17), Adult (18-64), Older Adult (65+).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0002555</AbbreviatedIRI>
        <Literal>ages eligible for study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0002556</AbbreviatedIRI>
        <Literal>The numerical value, if any, for the minimum age a potential participant must meet to be eligible for the clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0002556</AbbreviatedIRI>
        <Literal>minimum age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0002557</AbbreviatedIRI>
        <Literal>The numerical value, if any, for the maximum age a potential participant can be to be eligible for the clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0002557</AbbreviatedIRI>
        <Literal>maximum age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0002561</AbbreviatedIRI>
        <Literal>A type of eligibility criteria that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person&apos;s classification as female or male based on biological distinctions. Sex is distinct from gender-based eligibility.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0002561</AbbreviatedIRI>
        <Literal>sexes eligible for study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OBI_0300311</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OBI_0500000</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500006</AbbreviatedIRI>
        <Literal>Participants are assigned to one of two or more groups in parallel for the duration of the study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500014</AbbreviatedIRI>
        <Literal>Two or more interventions, each alone and in combination, are evaluated in parallel against a control group</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500026</AbbreviatedIRI>
        <Literal>A limited list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria and suitable for assisting potential participants in identifying clinical studies of interest.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500026</AbbreviatedIRI>
        <Literal>The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500027</AbbreviatedIRI>
        <Literal>A type of eligibility criteria. These are the reasons that a person is allowed to participate in a clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>http://www.icmje.org/recommendations/ 
https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0500027</AbbreviatedIRI>
        <Literal>key inclusion criteria</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OBI_0500028</AbbreviatedIRI>
        <Literal>A type of eligibility criteria. These are reasons that a person is not allowed to participate in a clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>http://www.icmje.org/recommendations/ 
https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OBI_0500028</AbbreviatedIRI>
        <Literal>key exclusion criteria</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://www.clinicaltrialsregister.eu/doc/EU_Clinical_Trials_Register_Glossary.pdf</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OGMS_0000073</AbbreviatedIRI>
        <Literal>1. the determination of the nature of a case of disease.
2. the art of distinguishing one disease from another.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000291</AbbreviatedIRI>
        <Literal>full title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000291</AbbreviatedIRI>
        <Literal>scientific title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000292</AbbreviatedIRI>
        <Literal>brief title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000292</AbbreviatedIRI>
        <Literal>lay title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000292</AbbreviatedIRI>
        <Literal>public title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000296</AbbreviatedIRI>
        <Literal>date of first enrollment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000296</AbbreviatedIRI>
        <Literal>study start</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0000297</AbbreviatedIRI>
        <Literal>The date the final participant was examined or received an intervention for purposes of final collection of data for the primary and secondary outcome measures and adverse events (for example, last participant’s last visit), whether the clinical study concluded according to the pre-specified protocol or was terminated.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000297</AbbreviatedIRI>
        <Literal>Completion Date</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000297</AbbreviatedIRI>
        <Literal>study completion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000298</AbbreviatedIRI>
        <Literal>completion date</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000299</AbbreviatedIRI>
        <Literal>primary completion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://www.clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0000302</AbbreviatedIRI>
        <Literal>The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record&apos;s availability on ClinicalTrials.gov (the first posted date).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000302</AbbreviatedIRI>
        <Literal>First submitted</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000302</AbbreviatedIRI>
        <Literal>date of registration in primary registry</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0000304</AbbreviatedIRI>
        <Literal>The recruitment status for the clinical study as a whole, based upon the status of the individual sites. If at least one facility in a multi-site clinical study has an Individual Site Status of &quot;Recruiting,&quot; then the Overall Recruitment Status for the study must be &quot;Recruiting.&quot;</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OPMI_0000304</AbbreviatedIRI>
        <Literal>http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OPMI_0000356</AbbreviatedIRI>
        <Literal>https://www.who.int/ictrp/network/jprn2/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000118"/>
        <AbbreviatedIRI>obo:OPMI_0000357</AbbreviatedIRI>
        <Literal>UMIN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000118"/>
        <AbbreviatedIRI>obo:OPMI_0000358</AbbreviatedIRI>
        <Literal>JapicCTI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0000359</AbbreviatedIRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in JMACCT. The format for the JMACCT registry number is “jRCTs” followed by a 9-digit number, e.g., jRCTs031190269.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000118"/>
        <AbbreviatedIRI>obo:OPMI_0000359</AbbreviatedIRI>
        <Literal>jRCTs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:OPMI_0000360</AbbreviatedIRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0000365</AbbreviatedIRI>
        <Literal>Combining a drug and device, a biological product and device; a drug and biological product; or a drug, biological product, and device</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <AbbreviatedIRI>obo:OPMI_0000376</AbbreviatedIRI>
        <Literal>behavioral</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <AbbreviatedIRI>obo:OPMI_0004508</AbbreviatedIRI>
        <Literal>Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies). (Formerly listed as &quot;Phase 0&quot;)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>obo:VO_0000002</AbbreviatedIRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Case_control_study</IRI>
        <Literal>Group of individuals with specific characteristics (for example, conditions or exposures) compared to group(s) with different characteristics, but otherwise similar.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Case_crossover_study</IRI>
        <Literal>Characteristics of case immediately prior to disease onset (sometimes called the hazard period) compared to characteristics of same case at a prior time (that is, control period).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Cohort_study</IRI>
        <Literal>Group of individuals, initially defined and composed, with common characteristics (for example, condition, birth year), who are examined or traced over a given time period.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Interventional_study</IRI>
        <Literal>Participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the effect of the intervention(s) on biomedical or other health related outcomes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Interventional_study</IRI>
        <Literal>clinical trail</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Observational_study</IRI>
        <Literal>Studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Participants in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the study participants. This includes when participants receive interventions as part of routine medical care, and a researcher studies the effect of the intervention.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/research.owl#Parallel_group_study</IRI>
        <Literal>Participants are assigned to one of two or more groups in parallel for the duration of the study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/study_design.owl#Crossover_study</IRI>
        <Literal>Participants receive one of two (or more) alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>http://purl.org/net/OCRe/study_design.owl#Single_group_study</IRI>
        <Literal>Clinical trials with a single arm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Australian_New_Zealand_clinical_trials_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Australian New Zealand clinical trials registry (ANZCTR). The format for the registry number is “ACTRN” followed by a 14-digit number, e.g., ACTRN12620000457943.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Australian_New_Zealand_clinical_trials_registry_identifier</IRI>
        <Literal>ANZCTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Australian_New_Zealand_clinical_trials_registry_identifier</IRI>
        <Literal>Australian New Zealand clinical trials registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Australian_New_Zealand_clinical_trials_registry_identifier</IRI>
        <Literal>http://www.anzctr.org.au/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Australian_New_Zealand_clinical_trials_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in  Brazilian Registry of Clinical Trials (ReBEC). The format for the ReBEC registry number is “RBR-” followed by  6 characters, e.g., RBR-4hb9qs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>Brazilian Registry of Clinical Trials identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>ReBEC identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>Brazilian clinical trial registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>http://www.ensaiosclinicos.gov.br/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Brazilian_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000118"/>
        <IRI>#Chinese_clinical_trial_registry_identifier</IRI>
        <Literal>ChiCTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Chinese_clinical_trial_registry_identifier</IRI>
        <Literal>Chinese Clinical Trial Register number</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chinese_clinical_trial_registry_identifier</IRI>
        <Literal>Chinese clinical trail registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Chinese_clinical_trial_registry_identifier</IRI>
        <Literal>http://www.chictr.org.cn/enIndex.aspx</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Chinese_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Cuban_public_registry_of_clinical_trials_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Cuban public registry of clinical trials (RPCEC). The format for the registry number is “RPCEC” followed by a 8-digit number, e.g., RPCEC00000306.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Cuban_public_registry_of_clinical_trials_identifier</IRI>
        <Literal>RPCEC identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cuban_public_registry_of_clinical_trials_identifier</IRI>
        <Literal>Cuban public registry of clinical trials identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Cuban_public_registry_of_clinical_trials_identifier</IRI>
        <Literal>http://registroclinico.sld.cu/en/home</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Cuban_public_registry_of_clinical_trials_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>The EU clinical trials register has been a primary registry in the World Health Organization (WHO&apos;s) Registry</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>EU-CTR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>EU clinical trials register</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>https://eudract.ema.europa.eu/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>https://www.clinicaltrialsregister.eu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#EU_clinical_trials_register</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#German_clinical_trials_register</IRI>
        <Literal>German clinical trials register is an organization to ....</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#German_clinical_trials_register</IRI>
        <Literal>DRKS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#German_clinical_trials_register</IRI>
        <Literal>German clinical trials register</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#German_clinical_trials_register</IRI>
        <Literal>https://www.drks.de/drks_web/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#German_clinical_trials_register</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#German_clinical_trials_register_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the German clinical trials register (DRKS). The format for the registry number is “DRKS” followed by a 8-digit number, e.g., DRKS00000494.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#German_clinical_trials_register_identifier</IRI>
        <Literal>DRKS identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#German_clinical_trials_register_identifier</IRI>
        <Literal>German clinical trials register identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#German_clinical_trials_register_identifier</IRI>
        <Literal>https://www.drks.de/drks_web/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#German_clinical_trials_register_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Indian clinical trial register. The format for the registry number is “CRTI/” followed  by a 4-digit number, followed by a slash, followed a 2-digit number, followed by a slash, followed a 6-digit number, e.g., CTRI/2020/03/024402.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>CRTI identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>Clinical Trials Registry - India identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>Indian clinical trial registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>http://ctri.nic.in/Clinicaltrials/login.php</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Indian_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the international standard randomised controlled trial register  (ISRCT). The format for the registry number is “ISRCTN” followed by a 10-digit number, e.g., ISRCTN14966673.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>ISRCTN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>International Standard Randomised Controlled Trial Number</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>International standard randomised controlled trial register identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>http://www.isrctn.com/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#International_standard_randomised_controlled_trial_register_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Iranian_registry_of_clinical_trials_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Iranian registry of clinical trials (IRCT). The format for the registry number is “IRCT” followed by a 14-digit number, one letter and again one or  two numbers, e.g., IRCT20100228003449N29.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Iranian_registry_of_clinical_trials_identifier</IRI>
        <Literal>IRCT identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Iranian_registry_of_clinical_trials_identifier</IRI>
        <Literal>Iranian registry of clinical trials identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Iranian_registry_of_clinical_trials_identifier</IRI>
        <Literal>http://www.irct.ir/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Iranian_registry_of_clinical_trials_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Korean_clinical_trial_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Korean Clinical Research Information Service (CRIS). The format for the registry number is “KCT” followed by a 7-digit number, e.g., KCT0004537.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Korean_clinical_trial_registry_identifier</IRI>
        <Literal>CRIS identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Korean_clinical_trial_registry_identifier</IRI>
        <Literal>Korean clinical trial registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Korean_clinical_trial_registry_identifier</IRI>
        <Literal>http://cris.nih.go.kr/cris/en/use_guide/cris_introduce.jsp</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Korean_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Lebanese_clinical_trials_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Lebanese clinical trials registry  (LBCTR). The format for the registry number is “LBCTR” followed by a 10-digit number, e.g., LBCTR2020043459.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Lebanese_clinical_trials_registry_identifier</IRI>
        <Literal>Lebanese clinical trials registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Lebanese_clinical_trials_registry_identifier</IRI>
        <Literal>LBCTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Lebanese_clinical_trials_registry_identifier</IRI>
        <Literal>http://lbctr.emro.who.int/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Lebanese_clinical_trials_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Pan_African_clinical_trial_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Pan African clinical trial register. The format for the registry number is “KCT” followed by a 15-digit number, e.g., PACTR202004893013257.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Pan_African_clinical_trial_registry_identifier</IRI>
        <Literal>PACTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pan_African_clinical_trial_registry_identifier</IRI>
        <Literal>Pan African clinical trial registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Pan_African_clinical_trial_registry_identifier</IRI>
        <Literal>https://pactr.samrc.ac.za/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Pan_African_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Peruvian_clinical_trial_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Peruvian clinical trial registry  (REPEC). The format for the registry number is “PER-” followed by a 3-digit number, folowed by a hyphen, followed by a 2-digit number e.g., PER-010-20.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Peruvian_clinical_trial_registry_identifier</IRI>
        <Literal>REPEC identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Peruvian_clinical_trial_registry_identifier</IRI>
        <Literal>Peruvian clinical trial registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Peruvian_clinical_trial_registry_identifier</IRI>
        <Literal>https://ensayosclinicos-repec.ins.gob.pe/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Peruvian_clinical_trial_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Sri_Lanka_clinical_trials_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Sri Lanka clinical trials registry (SLCTR ). The format for the registry number is “SLCTR /” followed  by a 4-digit number, followed by a slash, followed a 3-digit number, e.g., SLCTR/2020/010</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Sri_Lanka_clinical_trials_registry_identifier</IRI>
        <Literal>SLCTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sri_Lanka_clinical_trials_registry_identifier</IRI>
        <Literal>Sri Lanka clinical trials registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Sri_Lanka_clinical_trials_registry_identifier</IRI>
        <Literal>https://slctr.lk/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Sri_Lanka_clinical_trials_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#Thai_clinical_trials_registry_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the Thai clinical trials registry  (TCTR). The format for the registry number is “TCTR” followed by a 11-digit number, e.g., TCTR20200405001</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#Thai_clinical_trials_registry_identifier</IRI>
        <Literal>TCTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Thai_clinical_trials_registry_identifier</IRI>
        <Literal>Thai clinical trials registry identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Thai_clinical_trials_registry_identifier</IRI>
        <Literal>http://www.clinicaltrials.in.th/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#Thai_clinical_trials_registry_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#The_Netherlands_national_trial_register_identifier</IRI>
        <Literal>A centrally registered identifier that is assigned for a specific clinical trial registered in the The Netherlands national trial register (NTR). The format for the registry number is “NTR” followed by a 4-digit number, e.g., NL8498.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#The_Netherlands_national_trial_register_identifier</IRI>
        <Literal>NTR identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#The_Netherlands_national_trial_register_identifier</IRI>
        <Literal>The Netherlands national trial register identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#The_Netherlands_national_trial_register_identifier</IRI>
        <Literal>https://www.trialregister.nl/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#The_Netherlands_national_trial_register_identifier</IRI>
        <Literal>https://www.who.int/ictrp/network/primary/en/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#age_between_18_and_64</IRI>
        <Literal>adult (18-64)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#age_between_18_and_64</IRI>
        <Literal>age_between_18_and_64</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#age_between_18_and_64</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#age_between_birth_and_17_years</IRI>
        <Literal>child (birth-17)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#age_between_birth_and_17_years</IRI>
        <Literal>age_between_birth_and_17_years</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#age_between_birth_and_17_years</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#age_older_than_64</IRI>
        <Literal>older adult (65+)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#age_older_than_64</IRI>
        <Literal>age_older_than_64</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#age_older_than_64</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#healthy_volunteer_criterion</IRI>
        <Literal>A type of eligibility criteria that indicates whether people who do not have the condition/disease being studied can participate in that clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#healthy_volunteer_criterion</IRI>
        <Literal>Indication that participants who do not have a disease or condition, or related conditions or symptoms, under study in the clinical study are permitted to participate in the clinical study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#healthy_volunteer_criterion</IRI>
        <Literal>accepts healthy volunteers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#healthy_volunteer_criterion</IRI>
        <Literal>healthy volunteer criterion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#human_subjects_protection_review_board_status</IRI>
        <Literal>Indicate whether a clinical study has been reviewed and approved by at least one human subjects protection review board or such review is not required per applicable law (for example, 21 CFR Part 56, 45 CFR Part 46, or other applicable regulation).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#human_subjects_protection_review_board_status</IRI>
        <Literal>human subjects protection review board status</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#masking_design</IRI>
        <Literal>The party or parties involved in the clinical trial who are prevented from having knowledge of the interventions assigned to individual participants.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#masking_design</IRI>
        <Literal>blinding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#masking_design</IRI>
        <Literal>masking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#masking_design</IRI>
        <Literal>masking design</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#masking_design</IRI>
        <Literal>http://www.icmje.org/recommendations/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#masking_design</IRI>
        <Literal>http://www.who.int/ictrp/network/trds/en/index.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#number_of_participants</IRI>
        <Literal>The actual total number of participants that are enrolled in a clinical study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
        <IRI>#number_of_participants</IRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#number_of_participants</IRI>
        <Literal>enrollment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
            <Literal>http://www.who.int/ictrp/network/trds/en/index.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#number_of_participants</IRI>
        <Literal>sample size</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#number_of_participants</IRI>
        <Literal>number of participants</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#number_of_participants</IRI>
        <Literal>http://www.icmje.org/recommendations/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#other_outcome_measure_information</IRI>
        <Literal>Any other measurements, excluding post-hoc measures, that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study.
Each primary outcome measure information includes title, description and time frame.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
        <IRI>#other_outcome_measure_information</IRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#other_outcome_measure_information</IRI>
        <Literal>other pre-specified outcome measures</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#other_outcome_measure_information</IRI>
        <Literal>other outcome measure information</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#outcome_measure</IRI>
        <Literal>For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#outcome_measure</IRI>
        <Literal>outcome measure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#outcome_measure_result</IRI>
        <Literal>Data generated from measurement of experimental variables in a study, or for observational studies, from descriptions of patterns of diseases or traits or associations with exposures, risk factors or treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#outcome_measure_result</IRI>
        <Literal>outcome measure result</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#outcome_specification</IRI>
        <Literal>A description of the outcome measure in an interventional study or for observational studies, specific key measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#outcome_specification</IRI>
        <Literal>outcome specification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#outcome_specification</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#phase_not_applicable</IRI>
        <Literal>Trials without phases (for example, studies of devices or behavioral interventions).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasExactSynonym"/>
        <IRI>#phase_not_applicable</IRI>
        <Literal>N/A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#phase_not_applicable</IRI>
        <Literal>phase not applicable</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>A description of each primary outcome measure (or for observational studies, specific key measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment).
Each primary outcome measure information includes title, description and time frame.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
            <Literal>https://www.clinicaltrialsregister.eu/doc/EU_Clinical_Trials_Register_Glossary.pdf</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>primary end pont</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
            <Literal>https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>primary outcome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>primary outcome measure information</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#primary_outcome_measure_information</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#prospective_study_design</IRI>
        <Literal>Look forward using periodic observations collected predominantly following subject enrollment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#prospective_study_design</IRI>
        <Literal>prospective study design</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#retrospective_study_design</IRI>
        <Literal>Look back using observations collected predominantly prior to subject selection and enrollment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#retrospective_study_design</IRI>
        <Literal>retrospective study design</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#secondary_identifier</IRI>
        <Literal>An identifier(s) (ID), if any, other than the organization&apos;s Unique Protocol Identification Number or the NCT number that is assigned to the clinical study. This includes any unique clinical study identifiers assigned by other publicly available clinical trial registries. If the clinical study is funded in whole or in part by a U.S. Federal Government agency, the complete grant or contract number must be submitted as a Secondary ID.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#secondary_identifier</IRI>
        <Literal>Other identifiers besides the Trial Identifying Number allocated by the Primary Registry, if any.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#secondary_identifier</IRI>
        <Literal>secondary identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#secondary_outcome_measure_information</IRI>
        <Literal>A description of each secondary outcome measure (or for observational studies, specific secondary measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment).
Each secondary outcome measure information includes title, description and time frame.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
        <IRI>#secondary_outcome_measure_information</IRI>
        <Literal>https://prsinfo.clinicaltrials.gov/definitions.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
            <Literal>https://www.who.int/ictrp/network/trds/en/</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="oboInOwl:hasRelatedSynonym"/>
        <IRI>#secondary_outcome_measure_information</IRI>
        <Literal>key secondary outcome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#secondary_outcome_measure_information</IRI>
        <Literal>secondary outcome measure information</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <IRI>#secondary_outcome_measure_information</IRI>
        <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <Annotation>
            <AnnotationProperty abbreviatedIRI="obo:IAO_0000119"/>
            <Literal>https://clinicaltrials.gov/ct2/about-studies/glossary</Literal>
        </Annotation>
        <AnnotationProperty abbreviatedIRI="obo:IAO_0000115"/>
        <IRI>#study_result</IRI>
        <Literal>A study record that includes the summary results posted in the ClinicalTrials.gov results database. Summary results information includes participant flow, baseline characteristics, outcome measures, and adverse events (including serious adverse events).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#study_result</IRI>
        <Literal>study result</Literal>
    </AnnotationAssertion>
</Ontology>



<!-- Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi -->

